International Conference on Viral Hepatitis ICVH on February 10-11, 2025 in London, United Kingdom

Hepatitis
Viral Entry, New Models and Variants
cccDNA Function and Transcription
Adaptive Immune Responses
Reverse Transcription, Assembly, Morphogenesis
Regulatory Proteins and Host Factors
HCC and Carcinogenesiss
Pathogenesis
Innate Immune Responses
HBV or HCV Clinical Management
HBV or HCV Drug Resistance
HBV or HCV Treatment Challenges
Investigational Agents/New Strategies
Viral Hepatitis
Viral Hepatitis and Liver Disease
HAV
Virology
Epidemiology and control

HBV
Replication
New ORF\\\'s and viral proteins
Cryptic HBV
Variants and recombinants
New antivirals for HBV
Therapeutic vaccination for HBV
Prophylactic vaccination for HBV
Immunopathogenesis of HBV

HCV
Replication
ORFs and viral proteins
Variants, quasispecies and genotypes
New antivirals for HCV
Immunity and immunopathogenesis of HCV
Extrahepatic replication
Epidemiology

HDV
All delta

HEV
Virology
Epidemiology and control

NEW HEPATITIS VIRUSES
Candidate hepatitis viruses

CO-INFECTION
Hepatitis virus co-infection
Hepatitis and other viruses

HEPATOCELLULAR CARCINOMA
Molecular biology
Management and screening
Epidemiology and cofactors

RISK GROUPS AND SITUATIONS
Nosocomial transmission
Injecting drug use
Maternal transmission
Transfusion
Transplantation

TECHNOLOGY
Genomics
Proteomics
Quantitation of viral load
Mathematical modelling

SOCIAL SCIENCES
Attitudes and beliefs about hepatitis
Impact of hepatitis on families
Emergence of patient advocate groups
Hepatitis and the pharma